PDLIM2 was only highly expressed in the tumor tissues of four cancer types (acute myeloid leukemia, low-grade glioma, pancreatic adenocarcinoma, and tenosynovial giant cell tumor). Here, PDLIM2 is linked to central nervous system cancer.